The filamentous fungus Cunninghamella elegans ATCC 36112 metabolized within 72 h of incubation approximately 64% of the [1, added. The radioactive metabolites were extracted with ethyl acetate and separated by thin-layer chromatography and reversed-phase high-performance liquid chromatography. Seven metabolites were identified by 1H nuclear magnetic resonance, UV, and mass spectral techniques as 6-hydroxyacenaphthenone (24.8%), 1,2-acenaphthenedione (19.9%), trans-1,2-dihydroxyacenaphthene (10.3%), 1,5-dihydroxyacenaphthene (2.7%), 1-acenaphthenol (2.4%), 1-acenaphthenone (2.1%), and cis-1,2-dihydroxyacenaphthene (1.8%). Parallel experiments with rat liver microsomes indicated that the major metabolite formed from acenaphthene by rat liver microsomes was l-acenaphthenone. The fungal metabolism of acenaphthene was similar to bacterial and mammalian metabolism, since the primary site of enzymatic attack was on the two carbons of the five-member ring.
Polycyclic aromatic hydrocarbons (PAHs) are classified as priority toxic pollutants by the U.S. Environmental Protection Agency (18) . Many PAHs are toxic and/or carcinogenic and are considered to be potential health risks to humans (18) . Acenaphthene, a PAH containing three fused rings, is produced by combustion or pyrolysis of fossil fuels (17) and is also a constituent of coal tar (13) , tobacco smoke (23) , automobile exhaust (14) , and urban air (10) . Acenaphthene is used in the synthesis of plastics, dyes, and pesticides (30) and has been detected in effluents from petrochemical, pesticide, and wood-preservative industries (29) . Groundwater contamination by acenaphthene has also been previously reported (19) .
Although acenaphthene is considered nonmutagenic, it has been shown to induce nuclear and cytological changes in plants and microorganisms (31) . In fish, a concentration of 413 p.g of acenaphthene per liter of water caused lethargic behavior among juvenile fathead minnows (Pimephales promelas) (1) . Cairns and Nebeker (1) considered this behavior to be a sensitive indicator of toxicity.
Information on the microbial degradation of acenaphthene is limited (4) . Chapman (9) studied the metabolism of acenaphthene with Pseudomonas sp. and reported that oxidation in the C-1 and C-2 bridge forms 1-acenaphthenol and 1-acenaphthenone. A Beijerinckia sp. was shown to cooxidize acenaphthene to 1-acenaphthenone, 1-acenaphthenol, acenaphthene-cis-1,2-diol, and acenaphthenequinone (26) .
Under anaerobic conditions, no degradation of acenaphthene in sediment samples was observed (21) . However, Mihelcic and Luthy (21) observed microbial degradation of acenaphthene under denitrification conditions after an acclimation period of several weeks prior to the onset of microbial degradation.
The fungus Cunninghamella elegans, studied extensively in our laboratory, has shown the ability to metabolize low as well as high-molecular-weight PAHs to compounds which are usually less mutagenic than the parent compounds (4, 7, * Corresponding author. 25 ). The metabolic pathways have shown a greater tendency toward detoxification than the bioactivation pathways found more commonly in mammals (5-8, 20, 22, 25 Fractions eluting from the column were collected at 0.5-min intervals, and radioactivity was measured by liquid scintillation counting. described previously (24) . The ethyl acetate-extractable metabolites were concentrated, and the residue was dissolved in methanol and analyzed by HPLC and thin-layer chromatography.
Experiments with radiolabeled acenaphthene were conducted as described above with [1,8-14C] acenaphthene (1.06 ICi) added to duplicate flasks. As usual, 20 mg (130 p.mol) of unlabeled acenaphthene dissolved in 0.5 ml of dimethyl sulfoxide was also added to each flask. After incubation for 72 h, the entire flask contents were extracted and analyzed for metabolites. No metabolites were detected in the control flasks.
Rat liver microsomal metabolism of acenaphthene. Metabolites of acenaphthene from rat liver were obtained by in vitro incubation (8 ,umol of acenaphthene dissolved in 1 ml of dimethyl sulfoxide) in the dark at 37°C for 60 min in a 100-ml reaction mixture containing 5 mmol of Tris-HCI (pH 7.5), 0.3 mmol of magnesium chloride, 10 U of glucose 6-phosphate dehydrogenase (type XII; Sigma Chemical Co., St. Louis, Mo.), 10 mg of NADP+, 65 mg of glucose 6-phosphate, and 100 mg of liver microsomal protein from 3-methylcholanthrene-treated male Sprague-Dawley rats. After 60 min, the reaction was terminated by the addition of 100 ml of acetone. Acenaphthene and its metabolites were extracted with ethyl acetate (200 ml). The ethyl acetate extract was dried with anhydrous magnesium sulfate and evaporated to dryness under reduced pressure. The residue was redissolved in methanol and analyzed by HPLC.
Physical and chemical analyses. Fungal and rat liver microsomal metabolites of acenaphthene were separated with a Perkin-Elmer series 10 HPLC equipped with an LC-95 UV-visible absorbance detector (Perkin-Elmer Cetus, Inc., In experiments with [1,8-14C ]acenaphthene, 0.5-ml fractions were collected every 0.5 min and added to scintillation vials containing 7.0 ml of scintillation fluid (Ultima Gold; Packard Instrument Co., Inc., Meriden, Conn. Figure 1 shows the reversed-phase HPLC elution profile of the ethyl acetateextractable metabolites formed by incubation of [1,8- 14C]acenaphthene with C elegans for 72 h. Acenaphthene was metabolized to seven compounds, which were seen to elute at 15.0, 16.8, 21.4, 24.5, 26.9, 28.4, and 29.8 min. These are referred to as compounds I through VII, respectively. Acenaphthene was seen to elute at 40.8 min (Fig. 1) .
At time zero extraction, approximately 75% of the recovered radioactivity accounted for acenaphthene. However, the amount of acenaphthene decreased to less than 10% within 72 h while metabolites I to VII accounted for approximately 64% of the total recovered radioactivity. The major metabolite V (Fig. 1) indicates the probability that at least one hydroxy group was located on the fused five-member saturated ring. On the basis of the UV-visible absorption data and mass spectral data (Table 1) , compound I was proposed to be a dihydroxylated derivative of acenaphthene.
The structural identification of compound I was confirmed by NMR analysis. The 1H NMR spectrum of compound I ( Fig. 2A) shows that the nonexchangeable proton Hia has a chemical shift characteristic of hydroxy substitution (12) . The C-1 hydroxy group causes the adjacent protons H2a and H2b to become nonequivalent and exhibit large couplings to each other and to Hla; this also is characteristic of C-1-substituted acenaphthene (12) . It is apparent from the number of resonances that compound I ( Fig. 2A ) also contains one aromatic ring substituent. In addition, the ion fragmentation pattern seen in the mass spectrum of compound I is consistent with hydroxylation on both the aromatic ring and the fused five-member saturated ring ( Table 1 ). The upfield shift of H4 and the downfield shift of H6, because of ortho and pen effects, respectively, show that the phenol substitution is at C-5. The phenolic proton and the hydroxy proton (C-1-OH) were not detected because of rapid exchange. The hydroxy proton of metabolite I was detected indirectly by the elimination of a coupling constant at Hla after the addition of a trace of D20 (data not shown). On the basis of these spectral parameters, compound I was identified as 1,5-dihydroxyacenaphthene. indicates that both hydroxy groups were on the saturated ring (positions C-1 and C-2) ( Table 1 ). The comparison of UV-visible absorption spectral data with those from pub- lished reports (26) and mass spectral data suggested that compounds II and IV were dihydroxylated intermediates of acenaphthene.
The structural identification of compounds II and IV was confirmed by NMR analyses. The H NMR spectra of metabolites II and IV are shown in Fig. 2B and C. The NMR spectral parameters were similar to those described for compound I for the hydroxy groups on the C-1 and C-2 positions. However, the reduction in the number of resonances for metabolites II and IV is a consequence of (Table 1) . On the basis of the NMR spectral parameters described for compounds I, II, and IV and the observable hydroxy proton (Fig. 2D) , compound VII was identified as 1-acenaphthenol. The EI mass spectrum of compound V indicates a compound with two oxygens, with the molecular ion [M+] at mlz 184 and fragment ions at mlz 182, mlz 154, and m/z 126 (Table   1 ). Therefore, a keto-phenol was tentatively proposed for compound V. The keto substitution at C-1 for metabolite V was confirmed by its 1H NMR spectrum by the absence of a proton attributable to H1 and by the equivalence of the H2 protons (Fig. 3A) . Metabolite V also lacked one aromatic proton because of the hydroxy substitution at C-6. This substitution caused an upfield shift of H7 and a downfield shift of H5 because of ortho and pen effects, respectively. The phenolic proton was not detected because of rapid exchange. Thus, compound V was found to be 6-hydroxyacenaphthenone.
Direct-probe mass spectrometry analysis of compound VI showed a molecular ion at mlz 168 and a strong fragment ion at mlz 140 [M' -CO], indicating that the compound is a ketone. On the basis of NMR spectroscopy results similar to those described for compound V, compound VI was identified as 1-acenaphthenone (Fig. 3B) .
The To compare the fungal metabolism of acenaphthene with that of the mammalian metabolism of acenaphthene, rat liver microsomes from a 3-methylcholanthrene-treated rat were incubated with acenaphthene. The HPLC elution profile of metabolites formed from acenaphthene by rat liver microsomes showed that the major metabolite formed was 1-acenaphthenone. Identification of this metabolite was based on the fact that the retention time, UV-visible absorption spectrum, and EI mass spectrum were identical to those of the fungal metabolite VI (Table 1) . 
DISCUSSION
The fungus C. elegans metabolized acenaphthene via hydroxylation of both the aliphatic and aromatic rings to hydroxylated and keto derivatives of acenaphthene. We propose that the primary site of enzymatic attack by C. elegans is on the C-1 and C-2 bridge, which resulted in the formation of the secondary alcohol 1-acenaphthenol. This oxidative pathway is likely, since previous studies on the transformation of acenaphthene by bacteria (26) sequently, 1-acenaphthenol appears to have been oxidized to cis-and trans-1,2-dihydroxyacenaphthene.
The existing literature on bacterial and mammalian metabolism of acenaphthene indicates the formation of metabolites 1-acenaphthenol, 1-acenaphthenone, acenaphthene-cis-1,2-diol, 2-hydroxyacenaphthenone, and acenaphthenequinone (9, 11, 15, 16, 26, 27) . The oxidation of acenaphthene by Beijeinckia sp. was shown to occur via two successive monooxygenation steps and two subsequent dehydrogenation steps (26) . On the basis of these reports and the metabolites observed in our study, the pathway illustrated in Fig. 4 is proposed. The initial oxidative attack at the C-1 and C-2 positions of acenaphthene, with subsequent hydroxylation to form cis-and trans-dihydroxyacenaphthene, was expected, on the basis of the chemical reactivity and the ease of benzylic hydroxylation compared with aromatic ring hydroxylation.
Another proposed pathway (Fig. 4) includes the hydroxylation at both the C-1 and C-2 bridge and the aromatic ring of acenaphthene to form 1,5-dihydroxyacenaphthene. Additionally, formation of 1-acenaphthenone with subsequent hydroxylation of the aromatic ring to form 6-hydroxyacenaphthenone is proposed. Similar studies (2) show that naphthalene is oxidized by C elegans via a cytochrome P-450 monooxygenase to form naphthalene 1,2-oxide. Naphthalene 1,2-oxide isomerizes spontaneously to 1-naphthol via an NIH shift mechanism, indicating that naphthalene 1,2-oxide is a metabolic intermediate (2) . In the present study, oxidation at the C-S and C-6 positions to form 1,5-dihydroxyacenaphthene and 6-hydroxyacenaphthenone is analogous to the rearrangement of naphthalene 1,2-oxide to form 1-naphthol (2) .
Previous studies have shown that C. elegans metabolizes 3-methylcholanthrene, a potent carcinogenic PAH, via monohydroxylation of the methylene bridge to form 1-hydroxy-and 2-hydroxy-3-methylcholanthrene. The 1-and 2-keto derivatives of 3-methylcholanthrene and 1-hydroxy-3-methylcholanthrene trans-9,10-dihydrodiol were also previously reported (3) . The dihydrodiol has been implicated as a proximate carcinogen in mammalian systems. Similarly to the oxidation of the methylene bridge of 3-methylcholan- threne, the initial oxidation of acenaphthene by C. elegans is on the C-1 and C-2 bridge to form 1-acenaphthenol. Since phenols, quinones, trans-dihydrodiols, and epoxides have been identified as detoxification products of PAHs produced by C. elegans (7, 28) , the metabolic pathways reported in the present study may be helpful in determining the utility of fungi in the detoxification of this environmental pollutant.
